Funding

Johns Hopkins Drug Discovery is financially supported by a number of organizations ranging from federal and state agencies to industrial partners. We value each and every one of our sponsors, striving to make a difference in the lives of patients by developing new therapeutics.

Government

• Department of Defense

• Maryland Biotechnology Center Translational Research – TEDCO Maryland Innovation Initiative

• National Center for Advancing Translational Sciences

• National Cancer Institute

• National Eye Institute

• National Heart, Lung, and Blood Institute

• National Institute of Aging

• National Institute on Alcohol Abuse and Alcoholism

• National Institute of Allergy and Infectious Diseases

• National Institute of Biomedical Imaging and Bioengineering

• National Institute of Child Health and Human Development

• National Institute on Drug Abuse

• National Institute of Mental Health

• National Institute Neurological Disorders and Stroke

Disease Foundations/Philanthropy

• Alex’s Lemonade Stand Foundation

• Alleghany Health Network

• Alzheimer’s Association

• American Cancer Society

• American Chemical Society

• Children’s Cancer Foundation

• Crohn’s and Colitis Foundation

• Dana Foundation

• Foundation Thierry Latran

• Henry M. Jackson Foundation

• National Multiple Sclerosis Society

• Neurofibromatosis Therapeutic Acceleration Program

• Pancreatic Cancer Action Network

• Research Foundation for Mental Hygiene, Inc.

• Tau Consortium

Pharmaceutical

• Bayer

• Braeburn Pharma Inc.

• BioMotiv

• Celgene Inc.

• Cerecor, Inc.

• Diagnostic Biochips

• Dracen Pharmaceuticals

• Eisai, Inc.

• Helsinn Therapeutics

• Inception IBD Inc.

• Janssen Research & Development, LLC

• Lorem Therapeutics

• Maruho Co., Ltd.

• Pfizer Inc.

• PharmaMar, USA, Inc.

• Roche TCRC, Inc.

• Sanofi Innovation Awards Program

• Transcept, Inc.

• Trevena Inc.